Results 141 to 150 of about 23,985 (238)

Oncolytic virus and immunogenic cell death in cancer therapy. [PDF]

Tumour Virus Res
Cao G, Ding C, Dai J, Qiu X.
europepmc   +1 more source

Functional analysis and verification of GYG2 in oncolytic virus-infected glioma. [PDF]

BMC Cancer
Dong Y, Wang S, Wang C, Zhou J, Zhang Y, Yin X.   +5 more
europepmc   +1 more source

Developing a multimodal therapy for glioblastoma using oncolytic virus delivering CD19 and EGFRvIII antigens and bi-specific CARs. [PDF]

Nat Commun
Li J, Chaurasiya S, Sun G, Cui Q, Ye P, Qin Y, Zhou T, Wang X, Fong Y, Maus MV, Shi Y.   +10 more
europepmc   +1 more source

NRG-GI007: Phase 1 Study of OBP-301, An Oncolytic Virus, and Definitive Chemoradiation in Locally Advanced Esophageal Cancer. [PDF]

Int J Radiat Oncol Biol Phys
Ku GY, Winter K, Ilson D, Adusumilli PS, Nishimura M, Yock AD, Mehta RJ, Biran T, Frakes JM, Wu A, Miller ED, Klempner SJ, Moughan J, Hong TS, Williams TM.   +14 more
europepmc   +1 more source

Apoptotic modulators enhance oncolytic virus-induced cytokine killing in acute myeloid leukaemia (AML). [PDF]

Br J Cancer
Askar B, Heaton S, Barr T, Baugh R, Alzamel N, McConnell S, Jennings VA, Volpato M, Ralph C, Jain M, Kelly RJ, Parrish C, Errington-Mais F.   +12 more
europepmc   +1 more source

Multistage responsive microneedle delivery system loaded oncolytic virus for topical therapy of melanoma. [PDF]

Acta Pharm Sin B
Wang Z, Yan Z, Chen H, Wang Y, Shi Y, Jing Y, Ming R, Liu S, Jin P, Wu G, Huang L.   +10 more
europepmc   +1 more source

Engagement of the TCR against an oncolytic virus generates a population of effector CAR T cells with potent antitumor activity. [PDF]

Sci Adv
Liseth O, Appleton E, Kendall B, Thompson J, Sangsuwannukul T, Tonne J, Diaz RM, Evgin L, Patrikeev A, Sarbia N, Foo S, Harrington K, Ono M, Melcher A, Vile R.   +14 more
europepmc   +1 more source

TAMs-mediated resistance to oncolytic virus M1 in solid tumors. [PDF]

J Immunother Cancer
Liang X, Li J, Chen J, Chen C, Li H, Yan C, Guo C, Han Y, Liu W, Sai K, Lin Y, Yan G, Zhu W, Liu Y.   +13 more
europepmc   +1 more source

Enhancing Oncolytic Virus Therapy with Nanomedicine: A Review of Progress, Challenges, and Future Directions in a New Frontier of Cancer Treatment. [PDF]

Int J Nanomedicine
Qiu J, Liao Y, Kan D, Liao L, Yang K, Hu X, Wang Z, Yu H, Xie F, Liu Z.   +9 more
europepmc   +1 more source

An ex vivo permissivity assay to assess replication of the oncolytic virus VSV-GP in patient-derived tumor samples. [PDF]

Oncogene
Schoeps B, Estermann S, Berchtold S, Beil J, Yurttas C, Mayr M, Volland A, Tort AG, Glatz MC, Martin F, Smirnow I, Klammsteiner N, Kloker LD, Smolle M, Nolden T, Rettenmaier R, Kleemann R, Schwaiger T, Petersson M, Elbers K, Knobbe-Thomsen C, Lauer UM, Das K.   +22 more
europepmc   +1 more source